Imanova has world-leading expertise in imaging sciences and their application to the understanding of disease and translational drug development. An innovative joint venture, Imanova’s shareholders are the UK's Medical Research Council and three world-class London universities: Imperial College London, King’s College London and University College London. Imanova is a company with a depth of understanding in drug development and extensive experience using imaging to facilitate the development pipeline. Our academic expertise and extensive links with clinicians and scientists in our shareholder institutions provide unrivalled capabilities to facilitate drug development.
View Top Employees from Invicro UKWebsite | https://www.imanova.co.uk |
Revenue | $39.2 million |
Employees | 39 (15 on RocketReach) |
Founded | 2011 |
Phone | +44 20 8008 6027 |
Industry | Pharmaceuticals, Biotechnology, Health Diagnostics, Neuroscience, Healthcare, Health Care, Oncology, Infectious disease, Inflammation, Respiratory, Transformational Medicine, Fibrosis, Central Nervous System, Positron emission tomography, Magnetic resonance imaging, PET Imaging, MRI, Clinical Research, Preclinical Research, Biomarker Development |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Invicro UK employee's phone or email?
The Invicro UK annual revenue was $39.2 million in 2023.
15 people are employed at Invicro UK.
Invicro UK is based in London, Greater London.
The NAICS codes for Invicro UK are [3254, 32, 325].
The SIC codes for Invicro UK are [28, 283].